Dual Specificity CD19 and CD22 CAR-T Cell Immunotherapy for CD19+CD22+ Relapsed and Refractory Lymphoma
Phase 1
- Conditions
- Lymphoma
- Interventions
- Biological: Dual Specificity CD19 and CD22 CAR-T Cell Immunotherapy
- First Posted Date
- 2018-03-16
- Last Posted Date
- 2018-03-20
- Lead Sponsor
- Ruijin Hospital
- Target Recruit Count
- 10
- Registration Number
- NCT03468153
- Locations
- 🇨🇳
Shanghai Ruijin Hospital, Shanghai, Shanghai, China
Deep Brain Stimulation of the Bilateral Habenula for Treatment-Refractory Obsessive-Compulsive Disorder
Not Applicable
- Conditions
- Obsessive-Compulsive Disorder
- Interventions
- Device: Bilateral surgical implantation of DBS system to habenula
- First Posted Date
- 2018-03-13
- Last Posted Date
- 2018-03-29
- Lead Sponsor
- Ruijin Hospital
- Target Recruit Count
- 6
- Registration Number
- NCT03463590
- Locations
- 🇨🇳
Shanghai Ruijin Hospital Functional Neurosurgery, Shanghai, Shanghai, China
Three-port Versus Conventional Laparoscopic Surgery for Colorectal Cancer
Not Applicable
Recruiting
- Conditions
- Colorectal Cancer
- Interventions
- Procedure: Three-port Laparoscopic SurgeryProcedure: Conventional Laparoscopic Surgery
- First Posted Date
- 2018-02-08
- Last Posted Date
- 2020-02-13
- Lead Sponsor
- Ruijin Hospital
- Target Recruit Count
- 282
- Registration Number
- NCT03426514
- Locations
- 🇨🇳
Ruijin Hospital, Shanghai, Shanghai, China
Transanal Versus Laparoscopic Total Mesorectal Excision for Rectal Cancer
Not Applicable
Withdrawn
- Conditions
- Rectal Cancer
- Interventions
- Procedure: Laparoscopic total mesorectal excisionProcedure: Transanal total mesorectal excision
- First Posted Date
- 2018-01-29
- Last Posted Date
- 2020-02-17
- Lead Sponsor
- Ruijin Hospital
- Registration Number
- NCT03413930
- Locations
- 🇨🇳
Ruijin Hospital North, Shanghai, Shanghai, China
12 weekS Adjuvant dOcetaxel Plus trastuzumaB in Patients With Small, Node-negative, HER2-positive Breast cancER (SOBER)
- First Posted Date
- 2017-12-11
- Last Posted Date
- 2020-03-10
- Lead Sponsor
- Ruijin Hospital
- Target Recruit Count
- 112
- Registration Number
- NCT03367676
- Locations
- 🇨🇳
Ruijin Hospital, Shanghai, Shanghai, China
Lenalidomide Plus ICE in the Treatment of Refractory and Relapsed DLBCL
Phase 2
- Conditions
- Diffuse Large B-Cell Lymphoma Refractory
- Interventions
- First Posted Date
- 2017-12-08
- Last Posted Date
- 2020-03-11
- Lead Sponsor
- Ruijin Hospital
- Target Recruit Count
- 39
- Registration Number
- NCT03367143
- Locations
- 🇨🇳
Shanghai Ruijin Hospital, Shanghai, Shanghai, China
Pathological Fracture in Potentially Unstable Spinal Metastases of Breast Cancer
- Conditions
- Spinal MetastasesBreast Cancer
- First Posted Date
- 2017-12-08
- Last Posted Date
- 2020-10-08
- Lead Sponsor
- Ruijin Hospital
- Target Recruit Count
- 120
- Registration Number
- NCT03365973
- Locations
- 🇨🇳
Ruijin Hospital Shanghai Jiao Tong University School of Medicine, Shanghai, Shanghai, China
Verification of Novel Survival Prediction Algorithm for Patients With NSCLC Spinal Metastasis
- Conditions
- Spinal MetastasesNon-Small-Cell Lung Cancer Metastatic
- First Posted Date
- 2017-12-06
- Last Posted Date
- 2020-10-08
- Lead Sponsor
- Ruijin Hospital
- Target Recruit Count
- 140
- Registration Number
- NCT03363685
- Locations
- 🇨🇳
Ruijin Hospital Shanghai Jiao Tong University School of Medicine, Shanghai, Shanghai, China
Deep Brain Stimulation of Nucleus Accumbens for Methamphetamine Addiction
Not Applicable
- Conditions
- Treatment Methamphetamine Addiction
- Interventions
- Procedure: Bilateral surgical implantation of DBS system to NAc
- First Posted Date
- 2017-11-20
- Last Posted Date
- 2018-10-26
- Lead Sponsor
- Ruijin Hospital
- Target Recruit Count
- 10
- Registration Number
- NCT03347474
- Locations
- 🇨🇳
Shanghai Ruijin Hospital Functional Neurosurgery, Shanghai, Shanghai, China
DBS of the Habenula for Treatment- Resistant Major Depression
Not Applicable
Terminated
- Conditions
- Treatment Resistant Major Depression Disorder
- Interventions
- Procedure: Deep brain stimuation system implantation
- First Posted Date
- 2017-11-20
- Last Posted Date
- 2021-06-09
- Lead Sponsor
- Ruijin Hospital
- Target Recruit Count
- 7
- Registration Number
- NCT03347487
- Locations
- 🇨🇳
Shanghai Ruijin Hospital Functional Neurosurgery, Shanghai, Shanghai, China
© Copyright 2025. All Rights Reserved by MedPath